Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) fell 4.3% during mid-day trading on Wednesday . The stock traded as low as $18.00 and last traded at $18.00. Approximately 177 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 2,344 shares. The stock had previously closed at $18.80.
Shionogi & Co., Ltd. Stock Performance
The stock’s 50 day moving average price is $18.18 and its 200 day moving average price is $19.27.
About Shionogi & Co., Ltd.
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
Featured Stories
- Five stocks we like better than Shionogi & Co., Ltd.
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
